Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.50 5.38% 49.00 48.00 50.00 52.50 41.00 41.00 3,339,476 14:15:39
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 9.8 1.2 0.8 61.3 88

Omega Diagnostics Share Discussion Threads

Showing 16026 to 16049 of 18325 messages
Chat Pages: Latest  649  648  647  646  645  644  643  642  641  640  639  638  Older
DateSubjectAuthorDiscuss
28/10/2020
08:25
yeah but we know that already.
thehitman1
28/10/2020
08:24
They haven't made or sold a single test yet, that's what happened...
control1
28/10/2020
08:23
what the hell happened, down by 13%.
thehitman1
28/10/2020
08:18
“X KING OF TAJ MAHAL” 👑 Tickboo U made the right choice buddy stick to Odx, u remember I use to brag abt NCYT and how that share price went through the roof some time back, exactly same will happen with ODX and GDR.
riz000
28/10/2020
08:15
“X KING OF TAJ MAHAL” 👑 Control1 Control ur self!!!! Ur losing the plot, have patience u idiot! Those of you thinking of selling, just remember there is a presentation tonight . The market will be closed , if undisclosed information comes out during the presentation you are going to have to pay a premium in the morning. Be careful
riz000
28/10/2020
08:15
Hi Riz, to be honest will be in and out as have little Spare cash. 5k at 73p. Obvious it was going to bounce.Hope all is well.
tickboo
28/10/2020
08:14
They have invested the money in manufacturing, now needs the sales, and lots of them. if they do 500,000 a week at £1 profit then looking at £2-3 M/month. This could double and then add in the food intolerance etc and it support the current valuation. Not sure it really supports multiple of it though
money4me
28/10/2020
08:09
“X KING OF TAJ MAHAL” 👑 Relax ladies n gents Stop panicking!!! This will rise later on back to 90s again Hello Tickboo u back in Odx?
riz000
28/10/2020
08:04
Also by the looks of it antibody tests are not looking the best bet given how long immunity lasts. It is all about antigen tests so a good thing ODX is developing one, well Mologic is but they will manufacture it.
tickboo
28/10/2020
08:03
Buy at 50p :)
g2theary
28/10/2020
07:56
Financials a mess but cash in the bank more than enough given the likely revenue increase in the near term.Antigen test likely to commence validation in Feb then as tech transfer will take a couple of months. The antigen test a lot more complicated than antibody.
tickboo
28/10/2020
07:50
There will be a few looking green this morning.
gwr7
28/10/2020
07:46
Is that the GreenRichard thread you're referring to?
hodhasharon
28/10/2020
07:45
tom @TomInvestorUK #ODX £1.7M loss £7M cash £166Mcap
thejaba
28/10/2020
07:43
'SIGNIFICANTLY increase in revenue is the word to look at' Not exactly hard to improve the revenue is it. What happened to India?
eggy toast
28/10/2020
07:40
9 degrees its not a false statement its what the rns says.
thejaba
28/10/2020
07:38
A lot of eggs on faces soon thinks buywell I like eggs But on a plate --- fried
buywell3
28/10/2020
07:37
Where's the jam? Best of british to all on the softie thread :-)
gwr7
28/10/2020
07:34
Just one extract: "the Company remains on track to increase capacity to produce up to 200,000 AbC-19(TM) Rapid tests per week by the end of November, with the capacity contributing to the overall target of 300,000 lateral flow tests per week mentioned above" The historic numbers are pretty irrelevant in the scheme of things - though the core Food Intolerance business is recovering well anyway in H2. Interestingly, ODX state there are "significant near-term opportunities for this business unit in China". News flow is imminent here perhaps. The ELISA test update is slightly disappointing, but ODX are "optimistic that it will see further orders materialise from DHSC and other sources, both domestic and overseas" as regards Abingdon. Re the Mologic lateral flow antibody test, "we are seeing early sales traction with this product that provides confidence for performance in the second half of the financial year." Finally, the antigen test is looking good : "by the end of November, Omega would look to commence technical transfer of the test prior to commencing manufacturing". The m/cap here is still small imo if prospects start to become tangible as hoped.
rivaldo
28/10/2020
07:30
SIGNIFICANTLY increase in revenue is the word to look at. Forward not backwards.... Would make a nice bolt on for another bigger company to buy..
onehanded
28/10/2020
07:29
RNS as expected, still lots of cash and ramping up LFT's as expected. ELISA testing sales disappointing....CD4-200 progressing and Food Intolerance heading in the right direction....
barrywhit
28/10/2020
07:28
COVID will never go !!This is the new world .. I'm afraid.
amaretto1
28/10/2020
07:28
thejaba you make a false statement ."Revenue is £3m" . Think about it that makes £6m in a year as these results are for 6 months
9degrees
28/10/2020
07:27
Great RNS imho.
hodhasharon
Chat Pages: Latest  649  648  647  646  645  644  643  642  641  640  639  638  Older
ADVFN Advertorial
Your Recent History
LSE
ODX
Omega Diag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201130 14:32:31